PARI GmbH: PARI Hydrate Receives FDA Clearance
12/17/2007 8:29:33 AM
More...
|
PARI And Kamada Ltd. Collaborate To Develop Inhaled Alpha-1 Antitrypsin
11/21/2006 10:58:04 AM
More...
|
PARI Innovative Manufacturers Introduces New Technology For Respiratory Care
10/19/2005 5:12:16 PM
More...
|
PARI Aerosol Research Institute's Formulation Work And eFlow Featured In Corus Pharma, Inc.'s Positive Phase II Trial Results
10/19/2005 5:11:53 PM
More...
|
PARI GmbH's eFlow, An Electronic Aerosol Device For Medication Delivery, Receives FDA 510(k) Market Clearance
10/19/2005 5:11:24 PM
More...
|
PARI GmbH Granted Orphan Drug Designation For Inhaled Cyclosporine - Potential New Therapy For Lung
Transplant Patients
10/19/2005 5:10:41 PM
More...
|
Corus Pharma, Inc. Release: Aztreonam Data To Be Presented At European Cystic Fibrosis Society Conference
10/19/2005 5:08:55 PM
More...
|